antibiotics Archives · BioBuzz

MCEDC Interview: Greg Merril, CEO of Adaptive Phage Therapeutics

<img width="300" height="300" src="https://b2193782.smushcdn.com/2193782/wp-content/uploads/2019/03/gmerril-300x300.jpeg?lossy=1&strip=1&webp=1" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image" alt="" decoding="async" srcset="https://b2193782.smushcdn.com/2193782/wp-content/uploads/2019/03/gmerril-75x75.jpeg?lossy=1&strip=1&webp=1 75w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2019/03/gmerril-100x100.jpeg?lossy=1&strip=1&webp=1 100w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2019/03/gmerril-150x150.jpeg?lossy=1&strip=1&webp=1 150w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2019/03/gmerril.jpeg?size=240x240&lossy=1&strip=1&webp=1 240w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2019/03/gmerril-300x300.jpeg?lossy=1&strip=1&webp=1 300w" sizes="(max-width: 300px) 100vw, 300px" />

Published on : March 19, 2019September 26, 2020 Published by : Chris Frew

MCEDC Interview: Greg Merril, CEO of Adaptive Phage Therapeutics Adaptive Phage Therapeutics’ CEO, Greg Merril, was featured this week in MCEDC’s Built For Bio Video Series. David Petr, CEO of [….]

Adaptive Phage Therapeutics Hosts Book Launch Event for ‘The Perfect Predator’

<img width="300" height="300" src="https://b2193782.smushcdn.com/2193782/wp-content/uploads/2019/03/APT-bug-image-300x300.jpg?lossy=1&strip=1&webp=1" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image" alt="" decoding="async" loading="lazy" srcset="https://b2193782.smushcdn.com/2193782/wp-content/uploads/2019/03/APT-bug-image-75x75.jpg?lossy=1&strip=1&webp=1 75w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2019/03/APT-bug-image-100x100.jpg?lossy=1&strip=1&webp=1 100w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2019/03/APT-bug-image-150x150.jpg?lossy=1&strip=1&webp=1 150w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2019/03/APT-bug-image.jpg?size=240x240&lossy=1&strip=1&webp=1 240w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2019/03/APT-bug-image-300x300.jpg?lossy=1&strip=1&webp=1 300w" sizes="(max-width: 300px) 100vw, 300px" />

Published on : March 6, 2019March 6, 2019 Published by : Chris Frew

IMAGE CREDIT: https://theperfectpredator.com Adaptive Phage Therapeutics Hosts Book Launch Event for ‘The Perfect Predator’ March 6, 2019 This past weekend marked the launch of ‘The Perfect Predator: A Scientist’s Race [….]

“In Conversation” with Mina Izadjoo, President of IPS

<img width="270" height="300" src="https://b2193782.smushcdn.com/2193782/wp-content/uploads/2018/09/Mina-ISPE_HEADSHOTS_HIGH_RES-120-2-270x300.jpg?lossy=1&strip=1&webp=1" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image" alt="" decoding="async" loading="lazy" srcset="https://b2193782.smushcdn.com/2193782/wp-content/uploads/2018/09/Mina-ISPE_HEADSHOTS_HIGH_RES-120-2.jpg?size=54x60&lossy=1&strip=1&webp=1 54w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2018/09/Mina-ISPE_HEADSHOTS_HIGH_RES-120-2.jpg?size=108x120&lossy=1&strip=1&webp=1 108w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2018/09/Mina-ISPE_HEADSHOTS_HIGH_RES-120-2.jpg?size=162x180&lossy=1&strip=1&webp=1 162w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2018/09/Mina-ISPE_HEADSHOTS_HIGH_RES-120-2.jpg?size=216x240&lossy=1&strip=1&webp=1 216w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2018/09/Mina-ISPE_HEADSHOTS_HIGH_RES-120-2-270x300.jpg?lossy=1&strip=1&webp=1 270w" sizes="(max-width: 270px) 100vw, 270px" />

Published on : September 5, 2018March 4, 2021 Published by : Sarah Ellinwood

“In Conversation” with Mina Izadjoo, President of IPS In preparation for the upcoming CEO Talks Panel on Innovators Combating Drug Resistance, BioBuzz Contributor, Sarah Ellinwood, Ph.D. caught up with one [….]

Dr. Carol Nacy, CEO of Sequella, Takes on the Global Crisis of Anti-Microbial Resistance

<img width="270" height="284" src="https://b2193782.smushcdn.com/2193782/wp-content/uploads/2018/08/Carol-Nacy-Headshot-3-270x284.jpg?lossy=1&strip=1&webp=1" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image" alt="Carol Nacy, Ph.D." decoding="async" loading="lazy" srcset="https://b2193782.smushcdn.com/2193782/wp-content/uploads/2018/08/Carol-Nacy-Headshot-3.jpg?size=128x135&lossy=1&strip=1&webp=1 128w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2018/08/Carol-Nacy-Headshot-3.jpg?lossy=1&strip=1&webp=1 270w" sizes="(max-width: 270px) 100vw, 270px" />

Published on : August 27, 2018September 20, 2021 Published by : Steven Surdez

Dr. Carol Nacy, CEO of Sequella, Takes on the Global Crisis of Anti-Microbial Resistance For Dr. Carol Nacy, co-founder and CEO of Rockville, Maryland’s clinical-stage antibiotics developer Sequella, it all [….]